Whittier Trust’s ProShares Ultra NASDAQ Biotechnology BIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-15
Closed -$1.22K 1359
2026
Q1
$1.22K Sell
15
-60
-80% -$4.97K ﹤0.01% 1296
2025
Q4
$6.1K Hold
75
﹤0.01% 1207
2025
Q3
$4.83K Hold
75
﹤0.01% 1233
2025
Q2
$3.44K Hold
75
﹤0.01% 1378
2025
Q1
$3.61K Hold
75
﹤0.01% 1359
2024
Q4
$3.8K Buy
75
+60
+400% +$3.56K ﹤0.01% 1404
2024
Q3
$956 Buy
+15
New +$969 ﹤0.01% 1495

Other funds holding BIB

Whittier Trust's BIB Position: Q2 2026 in Review

Whittier Trust sold out of ProShares Ultra NASDAQ Biotechnology (BIB) in Q2 2026, closing a stake of 15 shares — an estimated $1.22K sold.

Whittier Trust first reported a position in BIB in Q3 2024 and held it in 7 quarters. The position peaked at $6.1K in Q4 2025. 5 funds tracked by Wall St. Rank hold BIB as of Q2 2026.

  • Whittier Trust reported no remaining ProShares Ultra NASDAQ Biotechnology position as of Q2 2026 after selling out during the quarter.
  • Whittier Trust sold 15 ProShares Ultra NASDAQ Biotechnology shares in Q2 2026, an estimated $1.22K.
  • Whittier Trust first reported a position in ProShares Ultra NASDAQ Biotechnology in Q3 2024 and held it in 7 quarters.
  • Whittier Trust's ProShares Ultra NASDAQ Biotechnology position peaked at $6.1K in Q4 2025.
  • 5 funds tracked by Wall St. Rank held ProShares Ultra NASDAQ Biotechnology as of Q2 2026.

Based on Whittier Trust's 13F filing for Q2 2026, filed 28 Jul 2026.